Nadia Spiccia is an associate in Kirkland’s Intellectual Property Litigation Practice Group in London. With over 12 years’ experience supporting global pharma/biopharma and a background in chemistry, Nadia leverages her legal and technical experience to provide strategic counselling.

Nadia’s practice focuses on complex cross border and multijurisdictional life sciences patent disputes requiring significant coordination across multiple forums at both first instance and on appeal including in Australia, Asia, Europe, UK, LATAM and Middle East.

Nadia provides IP leadership for pharma/biopharm product development and commercialisation in global markets – from initial scoping through to post-launch. She has developed and implemented global IP strategies that align with commercial objectives for more than 8 years at multi-national pharma/biopharma companies giving her first-hand experience in and knowledge of the industry.

Her expertise includes freedom-to-operate (FTO) patent assessments, ‘front end’ procurement and licensing agreements, IP strategy design such as patent circumvention/product redesign and alignment with regulatory procedures, patent prosecution, ex-US patent oppositions and devising, coordinating and executing patent strategies for complex multijurisdictional disputes (including complex damages inquiries) at a pan-European and global scale in the pharma/biopharma field.

Prior to joining Kirkland, Nadia was Head of Patent Litigation - ex NA at Sandoz responsible for the launch and litigation of Sandoz’s small molecule and biosimilars worldwide apart from North America. Prior to this Nadia was Head of Legal and Company Secretary - ANZ for Mylan (now Viatris).

Nadia was recognised as a Notable Practitioner - IP Stars by Managing IP in the 2021 edition, Corporate IP Star – Europe by Managing IP in the 2019-2020 editions and a Leading In-House Intellectual Property & TMT Lawyers – Australia by Doyle’s Guide in the 2019-2020 editions.


Thought Leadership


“1,3-Dipolar Cycloaddition−Decarboxylation Reactions of an Azomethine Ylide with Isatoic Anhydrides: Formation of Novel Benzodiazepinones,” Organic Letters, December 2011

“Exploration of Solvent free and/ or microwave assisted syntheses of bismuth(III) thiolates,” Green Chemistry, October 2007

“Synthesis of 5-Aryloxazolidines via 1,3- Dipolar Cycloaddition Reaction of a Non-Stabilized Azomethine Ylide with Aromatic Aldehydes,” Australian Journal of Chemistry, January 2007


Notable Practitioner – IP Stars, Managing IP, 2021

Corporate IP Stars – Europe, Managing IP, 2019–2020

Leading In-House Intellectual Property & TMT Lawyers – Australia, Doyle’s Guide, 2019–2020

Memberships & Affiliations

Royal Australian Chemical Institute

Intellectual Property Society of Australia and New Zealand


Admissions & Qualifications

  • 2009, Admitted to Practice as a Solicitor of the Supreme Court of Victoria, Australia
  • 2009, Admitted to the High Court of Australia


  • University of MelbourneMaster of Intellectual Property Law2018
  • Monash UniversityLL.B., LawFirst Class Honours2009
  • Monash UniversityB.Sc., Chemistry (Hons.)First Class Honours2009
  • Monash UniversityB.Sc., Chemistry2007